On September 15, 2023, the National Patent Office officially granted IGUICOO Company an invention patent for an indoor air conditioning system for allergic rhinitis.
The emergence of this revolutionary and innovative technology fills the gap in domestic research in related fields. By adjusting the indoor living microenvironment, this technology can greatly alleviate or even eliminate symptoms of allergic rhinitis, which is undoubtedly a major positive news for the rhinitis patients.
Allergic rhinitis is currently one of the most common allergic diseases. According to a survey, the northwest region of China is a high-risk area for allergic rhinitis. Wormwood, pollen, etc. are the main reasons for the high incidence of seasonal allergic rhinitis in this area. The typical symptoms are paroxysmal continuous sneezing, clear water like nasal mucus, nasal congestion, and itching.
IGUICOO has taken a different approach to address the global problem of allergic rhinitis, starting from the microenvironment in which patients are located. After years of research and development, it has finally successfully developed a system solution that alleviates the pain and suffering symptoms of rhinitis patients from multiple dimensions such as allergen removal and microenvironment creation.
IGUICOO has always been committed to becoming an industry leader in providing systematic solutions for human healthy living. The acquisition of the national invention patent for “an indoor air conditioning system for allergic rhinitis” further establishes IGUICOO’s leading position in the field of healthy air environment systems
We believe that by widely applying this technology, the quality of life of rhinitis patients can be improved. In the future, we will continue to innovate our technology, provide more innovative products and solutions, and help every family easily have a healthy living environment, enjoying the most comfortable and natural breathing!
Post time: Nov-29-2023
